Blockade Medical LLC officials announce two additions to the Barricade Coil System including an Enhanced Framing Coil and a new Complex Finishing Coil. These new products have received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) and European CE Mark.
“Blockade Medical’s responsiveness to clinical needs and ability to deliver new products to the market in a very short period of time is very impressive. The enhanced first loop design of the New Barricade Framing Coil will expand the types of aneurysms I can now treat with the Barricade Coil System,” commented Adnan Siddiqui, M.D., PhD, FAHA, Vice-Chairman and Associate Professor, Department of Neurosurgery at the State University of New York, Buffalo.
Commenting on Blockade Medical’s ability to rapidly innovate based upon physician feedback, Blockade Medical’s President and Chief Technology Officer Dave Ferrera stated, “We are very proud of the clinically relevant enhancements to the Barricade Coil Line that we have delivered to the market in the past year including a handheld detachment cable set, longer coils and the recent approval of the enhanced Framing and Complex Finishing Coils. As we develop future coil and endoluminal technologies, we will continue to develop products that will make a positive clinical impact for clinicians and patients while also delivering compelling economic savings to the health care system.” “In my clinical experience, the existing Barricade Finishing Coil delivers best in class softness and deliverability from a helical finishing coil. The new Complex Finishing coil should provide even more effective finishing of aneurysms due to its unique shape and is a clinically relevant addition to the product line,” said Spiros Blackburn, M.D., Assistant Professor of Neurosurgery at The University of Florida College of Medicine, Gainesville, Florida.
Source: Blockade Medical